Placemark Investments, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 172 filers reported holding HAEMONETICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Placemark Investments, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2014$1,275,000
+3.8%
34,092
-3.1%
0.02%0.0%
Q3 2014$1,228,000
-13.0%
35,176
-12.1%
0.02%
-8.0%
Q2 2014$1,411,000
+10.7%
40,021
+2.3%
0.02%
+4.2%
Q1 2014$1,275,000
-38.0%
39,116
-19.8%
0.02%
-29.4%
Q4 2013$2,056,000
-4.6%
48,791
-9.7%
0.03%
-17.1%
Q3 2013$2,155,000
+0.5%
54,057
+4.3%
0.04%
-10.9%
Q2 2013$2,145,00051,8500.05%
Other shareholders
HAEMONETICS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders